The weekly litigation news digest is live. Subscribe now

IP Verse

Transgenic Mice Expressing Chimeric Major Histocompatibility Complex (Mhc) Class Ii Molecules - EP2967015

The patent EP2967015 was granted to Regeneron Pharmaceuticals on Aug 9, 2023. The application was filed on Mar 11, 2014 under application number EP14718815A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2967015

REGENERON PHARMACEUTICALS
Application Number
EP14718815A
Filing Date
Mar 11, 2014
Status
Granted And Under Opposition
May 5, 2023
Publication Date
Aug 9, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBMar 5, 2024WICHMANNADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS6586251
DESCRIPTIONUS7294754
DESCRIPTIONWO2009114400
EXAMINATIONWO2014130667
INTERNATIONAL-SEARCH-REPORTUS2007209083
INTERNATIONAL-SEARCH-REPORTWO2005004592
INTERNATIONAL-SEARCH-REPORTWO2013063340
OPPOSITIONEP2770822
OPPOSITIONEP3272214
OPPOSITIONEP3590332
OPPOSITIONUS2007209083
OPPOSITIONUS2013111616
OPPOSITIONWO2013063340

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents